Lamellarin D bioconjugates II: Synthesis and cellular internalization of dendrimer and nuclear location signal derivatives

Bioconjugate Chemistry

Volumn 20, Issue 6, 2009, Pages 1112-1121

  Pla, Daniel ^a,b   Martí, Marc ^a   Farrera Sinfreu, Josep ^a,c   Pulido, Daniel ^a,c   Francesch, Andrés ^d   Calvo, Pilar ^d   Cuevas, Carmen ^d   Royo, Miriam ^b,c   Aligué, Rosa ^e   Albericio, Fernando ^a,b   Álvarez, Mercedes ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c Combinatorial Chemistry Unit Barcelona Science Park ^*  (Spain)

^d PHARMAMAR S A   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; POLYETHYLENE GLYCOLS;

BIOCONJUGATES; CELLULAR INTERNALIZATION; CYTOTOXIC; HUMAN TUMOR CELL LINES; LAMELLARINS; MDA-MB-231; NUCLEAR DISTRIBUTION; NUCLEAR LOCALIZATION SIGNAL; PARENT COMPOUNDS; SIGNAL PEPTIDE;

DENDRIMERS;

3 [2 [BIS[2 [BIS[2 [3 [2 [2 (3 AMINOPROPOXY]ETHOXY]ETHOXY]PROPYLAMINO] 2 OXOETHYL]AMINO]ETHYL]AMINO]ACETYL]LAMELLARIN D; 3 [3 [2 [2 [2 [2 [2 (2 AMINOETHOXY)ETHOXY]ETHOXY]ETHOXY]ETHOXY]ETHOXY]PROPANOYLOXY]LAMELLARIN D; 3 [GLYCYLGLYCYLASPARAGINYLLEUCYLSERINE]LAMELLARIN D; 3,11 DI TERT BUTOXYCARBONYL LAMELLARIN D; 4' [GLYCYLASPARAGINYLLEUCYLSERINE]LAMELLARIN D; 4',11 BIS(TERT BUTYLDIPHENYLSILYL)LAMELLARIN D; ANTINEOPLASTIC AGENT; DENDRIMER; MACROGOL; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INTERNALIZATION; NUCLEAR LOCALIZATION SIGNAL; SIGNAL TRANSDUCTION;

EID: 67649217117     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800504t     Document Type: Article

References (30)

1. Vicent, M. J., and Duncan, R. (2006) Polymer conjugates: nanosized medicines for treating cancer. Trends Biotechnol. 24, 39-47. (Pubitemid 43017749)
2. Torchilin, V. P. (2005) Lipid-core micelles for targeted drug delivery. Curr. Drug Delivery 2, 319-327. (Pubitemid 41282750)
3. Lukyanov, A. N., and Torchilin, V. P. (2004) Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv. Drug Delivery Rev. 56, 1273-1289. (Pubitemid 38510474)
4. Greenwald, R. B., Pendri, A., Conover, C. D., Zhao, H., Choe, Y. H., Martínez, A., Shum, K., and Guan, S. (1999) Drug delivery systems employing 1,4- or 1,6-elimination: poly(ethylene glycol) prodrugs of amine-containing compounds. J. Med. Chem. 42, 3657-3667. (Pubitemid 29445099)
5. Nori, A., and Kopecek, J. (2005) Intracellular targeting of polymer-bound drugs for cancer chemotherapy. Adv. Drug Delivery Rev. 57, 609-636. (Pubitemid 40267695)
6. de Koning, M. C., van der Marel, G. A., and Overhand, M. (2003) Synthetic developments towards PNA-peptide conjugates. Curr. Opin. Chem. Biol. 7, 734-740. (Pubitemid 37486118)
7. Yoshikawa, T., Sugita, T., Mukai, Y., Yamanada, N., Nagano, K., Nabeshi, H., Yoshioka, Y., Nakagawa, S., Abe, Y., Kamada, H., Tsunoda, S.-i., and Tsutsumi, Y. (2008) Organelle-targeted delivery of biological macromolecules using the protein transduction domain: potential applications for peptide aptamer delivery into the nucleus. J. Mol. Biol. 380, 777-782.
8. Boulanger, C., Di Giorgio, C., and Vierling, P. (2005) Synthesis of acridine-nuclear localization signal (NLS) conjugates and evaluation of their impact on lipoplex and polyplex-based transfection. Eur. J. Med. Chem. 40, 1295-1306. (Pubitemid 41618270)
9. Pla, D., Francesch, A., Calvo, P., Cuevas, C., Aligué, R., Albericio, F., and Álvarez, M. (2009) Lamellarin D bioconjugates I: synthesis and cellular internalization of PEG-derivatives. Bioconjugate Chem. . the previous article in the same issue.
10. Crespo, L., Sanclimens, G., Pons, M., Giralt, E., Royo, M., and Albericio, F. (2005) Peptide and amide bond-containing dendrimers. Chem. Rev. 105, 1663-1682. (Pubitemid 40773665)
11. Maeda, H., Wu, J., Sawa, T., Matsumura, Y., and Hori, K. (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65, 271-284. (Pubitemid 30122932)
12. Pla, D., Albericio, F., and Álvarez, M. (2008) Recent advances in lamellarin alkaloids: isolation, synthesis and activity. Anti-Cancer Agents Med. Chem. 8, 746-760.
13. Facompré, M., Tardy, C., Bal-Mayeu, C., Colson, P., Pérez, C., Manzanares, I., Cuevas, C., and Bailly, C. (2003) Lamellarin D: a novel potent inhibitor of topoisomerase I. Cancer Res. 63, 7392-7399. (Pubitemid 37413481)
14. Marco, E., Laine, W., Tardy, C., Lansiaux, A., Iwao, M., Ishibashi, F., Bailly, C., and Gago, F. (2005) Molecular determinants of topoisomerase I poisoning by lamellarins: comparison with camptothecin and structure-activity relationships. J. Med. Chem. 48, 3796-3807. (Pubitemid 40776854)
15. Kluza, J., Gallego, M. A., Loyens, A., Beauvillain, J. C., Fernández Sousa-Faro, J. M., Cuevas, C., Marchetti, P., and Bailly, C. (2006) Cancer cell mitochondria are direct proapoptotic targets for the marine antitumor drug lamellarin D. Cancer Res. 66, 3177-3187.
16. Cortés, F., Pastor, N., Mateos, S., and Domínguez, I. (2007) Topoisomerase inhibitors as therapeutic weapons. Expert Opin. Ther. Patents 17, 1-12.
17. Holden, J. A. (2001) DNA topoisomerases as anticancer drug targets: from the laboratory to the clinic. Curr. Med. Chem.: Anti-Cancer Agents 1, 1-25.
18. Dias, N., Vezin, H., Lansiaux, A., and Bailly, C. (2005) Topoisomerase inhibitors of marine origin and their potential use as anticancer agents. Top. Curr. Chem. 253, 89-108. (Pubitemid 44420840)
19. Pommier, Y. (2006) Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer 6, 789-802. (Pubitemid 44450467)
20. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P. (2007) Molecular Biology of the Cell, Garland Science, London.
21. Veronese, F. M., and Harris, J. M. (2008) Peptide and protein PEGylation III: advances in chemistry and clinical applications. Adv. Drug Delivery Rev. 60, 1-2. (Pubitemid 350181162)
22. IUPAC nomenclature of Lam-D: 3,11-dihydroxy-2,12-dimethoxy-14-(4-hydroxy- 3-methoxyphenyl)-6H[1]benzopyrano-[4′,3′:4,5]pyrrolo[2,1-a] isoquinoline-6-one.
23. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Waren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R. (1990) New colorimetric cytotoxicity assay for anticancer drug screening. J. Natl. Cancer Inst. 82, 1107-1112. (Pubitemid 20213250)
24. Boyd, M. R., and Paull, K. D. (1995) Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev. Res. 34, 91-104.
25. Mielke, C., Kalfalah, F. M., Christensen, M. O., and Boege, F. (2007) Rapid and prolonged stalling of human DNA topoisomerase I in UVA-irradiated genomic areas. DNA Repair 6, 1757-1763. (Pubitemid 350052727)
26. Cironi, P., Manzanares, I., Albericio, F., and Álvarez, M. (2003) Solid-phase total synthesis of the pentacyclic system lamellarins U and L. Org. Lett. 5, 2959-2962. (Pubitemid 37140812)
27. Bailly, C., Francesch, A., Mateo, C., Jiménez, J. A., Pastor, A., and Cuevas, C. (2004) Pharma Mar, S. A. U., WO 2004/014917 A2, pp 220.
28. Banwell, M., Flynn, B., and Hockless, D. (1997) Convergent total synthesis of Lamellarin K. Chem. Commun. 2259-2260. (Pubitemid 27510951)
29. The synthesis of 7 is part of a dendrimer project and will be published in due time.
30. Tulla-Puche, J., Torres, A., Calvo, P., Royo, M., and Albericio, F. (2008) N,N,N′,N′-Tetramethylchloroformamidinium hexafluorophosphate (TCFH), a powerful coupling reagent for bioconjugation. Bioconjugate Chem. 19, 1968-1971.